Oticon Medical Receives FDA Clearance To Market Innovative Bone Anchored Hearing System

Oticon Medical, a global medical device company within the William Demant Group, announced that it has obtained 501(k) clearance from the U.S. Food & Drug Administration (FDA) to market the innovative Ponto bone anchored hearing system. The Ponto System features an easy-to-operate computer fitting platform to enable a more precise match between patient and sound processor.